Evidence map›Paper›PMID 40874547›Full record

ArticleGlycobiology2025

Modeling glycans with AlphaFold 3: capabilities, caveats, and limitations.

Chin Huang, Natarajan Kannan, Kelley W Moremen

Abstract read
In one paragraph

Article in Glycobiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Site-specific O-glycans influence lacritin structure and multimerization in tears.Protein science : a publication of the Protein Society · 2026
    Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Bacillus cereus PelAThe Journal of biological chemistry · 2026
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Drug Discovery Strategies for Kallikrein-Related Peptidases.International journal of molecular sciences · 2025
    Review
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Chin HuangDepartment of Biochemistry and Molecular Biology, University of Georgia, 120 Green Street, Athens, GA 30602, United States.ORCID 0000-0002-4296-0400
Natarajan KannanDepartment of Biochemistry and Molecular Biology, University of Georgia, 120 Green Street, Athens, GA 30602, United States.ORCID 0000-0002-2833-8375
Kelley W MoremenDepartment of Biochemistry and Molecular Biology, University of Georgia, 120 Green Street, Athens, GA 30602, United States.ORCID 0000-0003-1768-582X

Funding

Heparan sulfate co-polymerase function and defects in diseaseR01GM154846 · NIGMS · UNIVERSITY OF GEORGIA · PI KELLEY W. MOREMEN · 2024 to 2026
$999k
NIGMS NIH HHS R01 GM154846NIH HHS GM154846U.S. National Science Foundation BioFoundry: Glycoscience Research, Education and Training 2400220
6 · The paper itself

Abstract

Glycans are complex carbohydrates that exhibit extraordinary structural complexity and stereochemical diversity while playing essential roles in many biological processes, including immune regulation, pathogen recognition, and cell communication. In humans, more than half of all proteins are glycosylated, particularly those in secretory and membrane-associated pathways, highlighting the importance of glycans in health and disease. The recent release of the AlphaFold 3 source code enables customizable modeling not only of proteins but also glycan-containing biomolecular complexes. We assessed the capacity of AlphaFold 3 to model glycans using several input formats and identified a hybrid syntax employing Chemical Component Dictionary (CCD)-based molecular building blocks linked by "bondedAtomPairs" (BAP) as most effective in generating stereochemically valid glycan models. This workflow was used to create a library of AlphaFold 3 input templates and corresponding structural models for various glycan classes. We further explored capabilities, limitations, and remediation strategies for modeling problematic structures. Glycan interactions were also modeled with glycosylation enzymes and lectins with benchmarking and validation against known crystal structures. This protocol-driven approach is valuable for generating stereochemically valid, static models of glycan-protein interactions to support hypothesis development and subsequent structural and functional validation. However, caution should be observed in overinterpretation of the static models since glycans are known to exhibit considerable conformational dynamics that can be further captured by equilibrium sampling using molecular dynamics-based approaches. By sharing benchmarked examples using the BAP syntax we aim to support broader evaluation of AlphaFold 3 in studying glycan-related mechanisms in biosynthesis, signaling, infection, and disease.

Indexed as

Models, MolecularPolysaccharidesSoftwareGlycosylationHumansPolysaccharidesAlphaFold 3glycan modelingglycan-protein interactionglycan stereochemistryglycoprotein modeling

Identifiers

PMID40874547
PMCPMC12448869

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.